Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 3
2019 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
ACR Appropriateness Criteria® Hematospermia.
Expert Panel on Urologic Imaging:; Hosseinzadeh K, Oto A, Allen BC, Coakley FV, Friedman B, Fulgham PF, Hartman MS, Heller MT, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Yoo DC, Remer EM, Eberhardt SC. Expert Panel on Urologic Imaging:, et al. J Am Coll Radiol. 2017 May;14(5S):S154-S159. doi: 10.1016/j.jacr.2017.02.023. J Am Coll Radiol. 2017. PMID: 28473071 Review.
ACR Appropriateness Criteria® Renal Failure.
Expert Panel on Urologic Imaging; Wong-You-Cheong JJ, Nikolaidis P, Khatri G, Dogra VS, Ganeshan D, Goldfarb S, Gore JL, Gupta RT, Heilbrun ME, Lyshchik A, Metter DF, Purysko AS, Savage SJ, Smith AD, Wang ZJ, Wolfman DJ, Lockhart ME. Expert Panel on Urologic Imaging, et al. J Am Coll Radiol. 2021 May;18(5S):S174-S188. doi: 10.1016/j.jacr.2021.02.019. J Am Coll Radiol. 2021. PMID: 33958111
ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update.
Expert Panel on Urologic Imaging; Turkbey B, Oto A, Allen BC, Akin O, Alexander LF, Ari M, Froemming AT, Fulgham PF, Gettle LM, Maranchie JK, Rosenthal SA, Schieda N, Schuster DM, Venkatesan AM, Lockhart ME. Expert Panel on Urologic Imaging, et al. J Am Coll Radiol. 2023 May;20(5S):S164-S186. doi: 10.1016/j.jacr.2023.02.012. J Am Coll Radiol. 2023. PMID: 37236741 Review.
ACR Appropriateness Criteria® Renal Transplant Dysfunction.
Expert Panel on Urologic Imaging:; Taffel MT, Nikolaidis P, Beland MD, Blaufox MD, Dogra VS, Goldfarb S, Gore JL, Harvin HJ, Heilbrun ME, Heller MT, Khatri G, Preminger GM, Purysko AS, Smith AD, Wang ZJ, Weinfeld RM, Wong-You-Cheong JJ, Remer EM, Lockhart ME. Expert Panel on Urologic Imaging:, et al. J Am Coll Radiol. 2017 May;14(5S):S272-S281. doi: 10.1016/j.jacr.2017.02.034. J Am Coll Radiol. 2017. PMID: 28473084 Review.
ACR Appropriateness Criteria® Indeterminate Renal Mass.
Expert Panel on Urologic Imaging; Wang ZJ, Nikolaidis P, Khatri G, Dogra VS, Ganeshan D, Goldfarb S, Gore JL, Gupta RT, Hartman RP, Heilbrun ME, Lyshchik A, Purysko AS, Savage SJ, Smith AD, Wolfman DJ, Wong-You-Cheong JJ, Lockhart ME. Expert Panel on Urologic Imaging, et al. J Am Coll Radiol. 2020 Nov;17(11S):S415-S428. doi: 10.1016/j.jacr.2020.09.010. J Am Coll Radiol. 2020. PMID: 33153554
ACR Appropriateness Criteria® Acute Pyelonephritis.
Expert Panel on Urologic Imaging:; Nikolaidis P, Dogra VS, Goldfarb S, Gore JL, Harvin HJ, Heilbrun ME, Heller MT, Khatri G, Purysko AS, Savage SJ, Smith AD, Taffel MT, Wang ZJ, Wolfman DJ, Wong-You-Cheong JJ, Yoo DC, Lockhart ME. Expert Panel on Urologic Imaging:, et al. J Am Coll Radiol. 2018 Nov;15(11S):S232-S239. doi: 10.1016/j.jacr.2018.09.011. J Am Coll Radiol. 2018. PMID: 30392592
ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging.
Expert Panel on Urologic Imaging:; Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. Expert Panel on Urologic Imaging:, et al. J Am Coll Radiol. 2017 May;14(5S):S245-S257. doi: 10.1016/j.jacr.2017.02.026. J Am Coll Radiol. 2017. PMID: 28473080 Review.
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer.
Expert Panel on Urologic Imaging; Allen BC, Oto A, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Lloyd S, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Vapiwala N, Venkatesan AM, Wang CL, Yoo DC, Lockhart ME. Expert Panel on Urologic Imaging, et al. J Am Coll Radiol. 2019 Nov;16(11S):S417-S427. doi: 10.1016/j.jacr.2019.05.026. J Am Coll Radiol. 2019. PMID: 31685109 Review.
ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
Expert Panel on Urologic Imaging:; Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM. Expert Panel on Urologic Imaging:, et al. J Am Coll Radiol. 2018 May;15(5S):S132-S149. doi: 10.1016/j.jacr.2018.03.019. J Am Coll Radiol. 2018. PMID: 29724417
ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer.
Expert Panel on Urologic Imaging:; van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley FV, Froemming AT, Fulgham PF, Hosseinzadeh K, Maranchie JK, Mody RN, Schieda N, Schuster DM, Venkatesan AM, Wang CL, Lockhart ME. Expert Panel on Urologic Imaging:, et al. J Am Coll Radiol. 2018 May;15(5S):S150-S159. doi: 10.1016/j.jacr.2018.03.020. J Am Coll Radiol. 2018. PMID: 29724418